<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Collaborative Study Group for the Study of <z:hpo ids='HP_0001297'>Stroke</z:hpo> in Young Women studied 598 women from age 15 to 44 years with cerebrovascular disease </plain></SENT>
<SENT sid="1" pm="."><plain>They found that the use of oral contraceptives was significantly more prevalent in women who had suffered a thrombotic <z:hpo ids='HP_0001297'>stroke</z:hpo> than in women who had not had <z:hpo ids='HP_0001297'>strokes</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The risk of thrombotic <z:hpo ids='HP_0001297'>stroke</z:hpo> was estimated to be nine times greater in users of oral contraceptives than in nonusers </plain></SENT>
<SENT sid="3" pm="."><plain>We report a case in which a previously healthy man who was using an oral contraceptive drug developed middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>In the absence of other predisposing factors in this case, it appears that the <z:e sem="disease" ids="C0596298" disease_type="Disease or Syndrome" abbrv="">cerebrovascular occlusion</z:e> was related to <z:chebi fb="0" ids="50114">estrogen</z:chebi> administration </plain></SENT>
<SENT sid="5" pm="."><plain>The occurrence of persistent severe <z:hpo ids='HP_0002315'>headaches</z:hpo> in patients using estrogenic hormones may be a clue to impending <z:e sem="disease" ids="C0596298" disease_type="Disease or Syndrome" abbrv="">cerebrovascular occlusion</z:e> </plain></SENT>
</text></document>